Literature DB >> 3941968

Long-term follow-up of large or invasive pituitary adenomas.

N Hashimoto, H Handa, J Yamashita, T Yamagami.   

Abstract

A long-term follow-up study of pituitary adenomas showed that 60 out of 83 patients with mild or moderate suprasellar extension, but only three out of 19 patients with huge or invasive adenomas, were alive at a mean post-operative period of 12.8 and 12 years, respectively. Cerebral ischemic attacks and complications of radiotherapy affected their fate and quality of survival. Patients in the post-computed tomography scan era had a good prognosis, and this may be due partly to the brevity of the postoperative period.

Entities:  

Mesh:

Year:  1986        PMID: 3941968     DOI: 10.1016/0090-3019(86)90114-x

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  11 in total

1.  Long-term results of radiation therapy for pituitary adenoma.

Authors:  M Kokubo; K Sasai; Y Shibamoto; T Aoki; N Oya; M Mitsumori; J A Takahashi; N Hashimoto; M Hiraoka
Journal:  J Neurooncol       Date:  2000-03       Impact factor: 4.130

2.  Role of transsphenoidal operation in the management of pituitary adenomas with suprasellar extension.

Authors:  O Bynke; J Hillman
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

3.  Percutaneous transluminal angioplasty in a patient with internal carotid artery stenosis following gamma knife radiosurgery for recurrent pituitary adenoma.

Authors:  Hidemichi Ito; Hidetaka Onodera; Taigen Sase; Masashi Uchida; Hiroyuki Morishima; Kotaro Oshio; Takashi Shuto; Yuichiro Tanaka
Journal:  Surg Neurol Int       Date:  2015-05-28

4.  Non-invasive radiomics approach potentially predicts non-functioning pituitary adenomas subtypes before surgery.

Authors:  Shuaitong Zhang; Guidong Song; Yali Zang; Jian Jia; Chao Wang; Chuzhong Li; Jie Tian; Di Dong; Yazhuo Zhang
Journal:  Eur Radiol       Date:  2018-03-23       Impact factor: 5.315

5.  A simple method of estimating the size of large pituitary adenomas.

Authors:  A P Jones; A J Keogh
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

6.  Association of expression of Leucine-rich repeats and immunoglobulin-like domains 2 gene with invasiveness of pituitary adenoma.

Authors:  Huaqiu Zhang; Qin Yan; Shutian Xu; Yibo Ou; Fei Ye; Baofeng Wang; Ting Lei; Dongsheng Guo
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

Review 7.  Intracranial metastatic disease rarely involves the pituitary: retrospective analysis of 935 metastases in 155 patients and review of the literature.

Authors:  James C Marsh; Shalini Garg; Julie A Wendt; Benjamin T Gielda; Julius V Turian; Arnold M Herskovic
Journal:  Pituitary       Date:  2010-09       Impact factor: 4.107

8.  Management of large and giant pituitary adenomas with suprasellar extensions.

Authors:  Junko Matsuyama; Tsukasa Kawase; Koichiro Yoshida; Mitsuhiro Hasegawa; Yuichi Hirose; Shinya Nagahisa; Shinnichi Watanabe; Hirotoshi Sano
Journal:  Asian J Neurosurg       Date:  2010-01

Review 9.  Ischemic stroke after radiation therapy for pituitary adenomas: a systematic review.

Authors:  A van Westrhenen; I S Muskens; J J C Verhoeff; T R S Smith; M L D Broekman
Journal:  J Neurooncol       Date:  2017-06-28       Impact factor: 4.130

10.  Cerebral infarction after fractionated stereotactic radiation therapy of benign anterior skull base tumors.

Authors:  Arnar Astradsson; Per Munck Af Rosenschöld; Lars Poulsgaard; Lars Ohlhues; Svend Aage Engelholm; Ulla Feldt-Rasmussen; Reginald Marsh; Henrik Roed; Marianne Juhler
Journal:  Clin Transl Radiat Oncol       Date:  2019-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.